NASDAQ:MYOK
Delisted
MyoKardia Stock News
$224.91
+0 (+0%)
At Close: May 27, 2022
Club cricket set to resume in Australia from June 6
05:33am, Sunday, 17'th May 2020
Clubs will be required to complete a COVID-19 safety plan assessment and submit it to the Northern Territory Government before they can play. Some details are still being worked out with Cricket Austr
Should You Buy MyoKardia Stock After This Week’s 96% Gain?
10:51am, Saturday, 16'th May 2020
MyoKardia (NASDAQ: MYOK) soared 96% this week after reporting its investigational heart drug met primary and all secondary endpoints in a phase 3 clinical trial. The clinical stage biotech company w
The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO
12:00am, Friday, 15'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 14)
Allogene Therapeutics Inc (...
Digital Comic Museum Offers Free Golden Age Comics for Download
12:02pm, Thursday, 14'th May 2020
Download free Golden Age comics at Digital Comic Museum!
Myriad's Ovarian Cancer Test Approved, And Other News: The Good, Bad And Ugly Of Biopharma
01:22pm, Wednesday, 13'th May 2020
Myriad's ovarian cancer test has been approved by the FDA. MyoKardia reports positive phase 3 data. ACRX reports earnings.
MyoKardia Announces Pricing of Public Offering of Common Stock
01:34am, Wednesday, 13'th May 2020
MyoKardia, Inc. (MYOK), a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, today announced the pricing of a
6 Stocks To Watch: ABBV, FSLY, GDOT, PTGX, SIEN, UNFI
12:00am, Wednesday, 13'th May 2020
Stocks Analysis by Harry Boxer covering: Novavax Inc, Overstockcom Inc, United Natural Foods Inc, B&G Foods Inc. Read Harry Boxer's latest article on Investing.com
Why MyoKardia (MYOK) Stock Could Rise Another 30%
05:43pm, Tuesday, 12'th May 2020
Biotech stocks have soared in 2020 on the back of promising COVID-19 vaccine or treatment data. But the trend for biotechs to surge dramatically is not one limited to only pandemic related stocks. Cas
U.S. RESEARCH ROUNDUP-Digital Realty Trust, Pilgrims Pride, Terraform Power
07:26am, Tuesday, 12'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Digital Realty Trust, Pilgrims Pride and Terraform Power,
on Tuesday.
HIGH
Cornerstone OnDemand, Inc. (CSOD) CEO Adam Miller on Q1 2020 Results - Earnings Call Transcript
06:09am, Tuesday, 12'th May 2020
Cornerstone OnDemand, Inc. (NASDAQ:CSOD) Q1 2020 Results Earnings Conference Call May 11, 2020 05:00 PM ET Company Participants Jason Gold - Vice President-Fina
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
MyoKardia Announces Proposed Public Offering of Common Stock
08:02pm, Monday, 11'th May 2020
MyoKardia, Inc. (MYOK), a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases, today announced that it has comme
Is the Options Market Predicting a Spike in MyoKardia (MYOK) Stock?
02:50pm, Monday, 11'th May 2020
Investors need to pay close attention to MyoKardia (MYOK) stock based on the movements in the options market lately.
Why MyoKardia Stock Is on Fire Today
02:49pm, Monday, 11'th May 2020
MyoKardia (NASDAQ: MYOK), a clinical-stage biotech, is having a tremendous Monday morning. Ahead of the opening bell, MyoKardia announced that its experimental obstructive hypertrophic cardiomyopathy
